Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 74 peer-reviewed journal articles Updated
Medical Genetics · Hypergonadotropic Hypogonadism and Cataracts

Hypergonadotropic Hypogonadism and Cataracts: A Patient Guide

At a Glance

Hypergonadotropic hypogonadism with cataracts is a rare clinical pattern, not necessarily one disease. Genetic evaluation may identify an underlying syndrome, while hormone replacement and coordinated eye care support growth, vision, and long-term health.

Finding out that you or your child has both hypergonadotropic hypogonadism and cataracts is often the start of a journey into rare disease medicine. This combination of symptoms is not a single disease by itself; instead, it serves as a clinical pattern that warrants evaluation for a syndromic genetic cause, among other possibilities [1]. Because certain genes are responsible for building parts of both the eyes and the reproductive system, a single genetic change can affect these two seemingly unrelated areas at once [2]. This pattern, while rare, helps medical teams narrow down the search for a diagnosis among syndromes such as Marinesco-Sjögren syndrome, Martsolf syndrome, or CWC27-related disorders [3][4].

The hormonal side of this journey involves primary gonadal failure, a condition where the ovaries or testes do not produce the sex hormones the body needs for puberty and long-term health [5]. Because the brain recognizes this deficiency, it sends out high levels of “signal” hormones—the hypergonadotropic part of the name—in a failed attempt to stimulate the system [6]. If primary gonadal insufficiency is confirmed, managing this may involve hormone replacement therapy (HRT) tailored to age and anatomy to allow for natural growth, protect bone density, and support overall development during the transition into adulthood [7][8].

At the same time, the presence of cataracts—a clouding of the eye’s lens—often requires specialized vision care from a very early age. In some of these syndromes, the cataracts are congenital (present at birth) or appear shortly after, interfering with how the brain learns to see [9]. Depending on whether the cataract interferes with vision, treatment may involve surgical removal of the cloudy lens followed by a dedicated routine of glasses, contact lenses, or patching to ensure the best possible visual outcome [10][11]. Regular monitoring by an ophthalmologist is essential to watch for related issues like glaucoma or changes in the retina [12].

Navigating these challenges can be overwhelming, especially when a definitive genetic name for the condition has not yet been found. This period, known as the diagnostic odyssey, requires a team of specialists—including geneticists, endocrinologists, and ophthalmologists—to work in close coordination [13][14]. While the search for a specific genetic “label” continues, the focus of care remains on managing the symptoms at hand, protecting future health, and supporting your family through the practical and emotional aspects of living with a rare condition [15]. With the right team and consistent monitoring, it is possible to build a clear roadmap for the future that prioritizes both medical stability and quality of life [16].

In this guide

6 chapters

01

Understanding Your Symptoms: Hypergonadotropic Hypogonadism and Cataracts

Learn what hypergonadotropic hypogonadism and cataracts may mean together, which genetic conditions can cause this pattern, and how doctors evaluate it.

02

The Genetic Search: Syndromes and Differential Diagnosis

Learn how doctors compare genetic syndromes causing hypergonadotropic hypogonadism and cataracts, and when whole exome sequencing or follow-up testing may help.

03

Managing the Endocrine Side: Hypergonadotropic Hypogonadism

Learn how hypergonadotropic hypogonadism is diagnosed and treated, including hormone replacement, bone health, fertility options, and genetic counseling.

04

Managing the Ocular Side: Cataracts and Vision

Learn about cataracts in hypergonadotropic hypogonadism-cataract syndrome, including eye exams, surgery, lenses, patching, and lifelong glaucoma checks.

05

Building Your Medical Team and Preparing for Visits

Learn how to build your care team for hypergonadotropic hypogonadism-cataract syndrome, prepare for specialist visits, coordinate genetic, eye, and hormone care.

06

Living with a Rare or Undiagnosed Condition

Learn how to live with hypergonadotropic hypogonadism-cataract syndrome during diagnostic uncertainty, including monitoring, warning signs, and support.

Common questions in this guide

What does it mean to have hypergonadotropic hypogonadism and cataracts together?
This is a rare clinical pattern rather than a single diagnosis. It means the ovaries or testes are not making enough sex hormones and the eye lens is cloudy, so clinicians often look for an underlying genetic condition that can affect both systems.
Could a genetic syndrome be causing both problems?
Yes, some genetic changes affect development of both the eyes and reproductive system. A genetics team may consider conditions such as Marinesco-Sjögren syndrome, Martsolf syndrome, or CWC27-related disorders, but testing and clinical findings are needed to determine the cause.
How is the hormone problem treated?
Primary gonadal failure may be treated with hormone replacement therapy chosen for the person's age and anatomy. Treatment can support puberty and growth, help protect bone density, and support health during the transition to adulthood.
Do cataracts always need surgery?
Not always; surgery is considered when a cataract interferes with vision. After removal, children or adults may need glasses or contact lenses and, in some cases, patching, with regular ophthalmology visits to monitor for glaucoma or retinal changes.
What happens if the first genetic test is negative?
A negative initial test does not necessarily explain the combination or rule out a genetic cause. Ask the genetics team what additional testing, medical-history review, or future re-evaluation may be appropriate while treatment and eye and hormone monitoring continue.
Which doctors should coordinate care for this combination of conditions?
Care often involves a medical geneticist, endocrinologist, and ophthalmologist, with a genetic counselor helping explain testing and results. Ask who will coordinate information and serve as the lead so vision, hormone, and genetic plans fit together.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on our current test results, what is the most likely genetic cause for this combination of symptoms?
  2. 2.Which specialist will act as the 'lead' for our medical team to ensure all findings are shared?
  3. 3.What is the immediate priority—addressing vision through surgery or managing hormone levels?
  4. 4.If initial genetic testing is negative, what is the next step in our diagnostic search?
  5. 5.Can you connect us with a genetic counselor who has experience with multisystem syndromes?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (16)
  1. 1

    Hypogonadotropic hypogonadism due to variants in RAB3GAP2: expanding the phenotypic and genotypic spectrum of Martsolf syndrome.

    Xu W, Plummer L, Quinton R, et al.

    Cold Spring Harbor molecular case studies 2020; (6(3)) doi:10.1101/mcs.a005033.

    PMID: 32376645
  2. 2

    Case report of four siblings in southeast Turkey with a novel RAB3GAP2 splice site mutation: Warburg micro syndrome or Martsolf syndrome?

    Gumus E

    Ophthalmic genetics 2018; (39(3)):391-395 doi:10.1080/13816810.2018.1432065.

    PMID: 29419336
  3. 3

    Muscle Imaging Approaches in Marinesco-Sjögren Syndrome: A Systematic Review and Two New Clinical Reports.

    Buchignani B, Vega G, Pasquariello R, et al.

    Children (Basel, Switzerland) 2026; (13(3)) doi:10.3390/children13030359.

    PMID: 41897072
  4. 4

    Exome sequencing revealed variants in SGCA and SIL1 genes underlying limb girdle muscular dystrophy and Marinesco-Sjögren syndrome patients.

    Faheem A, Masud R, Nasir R, et al.

    Molecular biology reports 2024; (51(1)):853 doi:10.1007/s11033-024-09746-5.

    PMID: 39060875
  5. 5

    Mutation analysis of the FOXL2 and BMP15 genes in patients with premature ovarian insufficiency.

    Mutlu MB, Topçu V, Çetinkaya ŞE, et al.

    Turkish journal of obstetrics and gynecology 2026; (23(2)):139-145 doi:10.4274/tjod.galenos.2026.68957.

    PMID: 42108981
  6. 6

    Paediatric Wolfram syndrome Type 1: should gonadal dysfunction be part of the diagnostic criteria?

    Frontino G, Di Tonno R, Stancampiano MR, et al.

    Frontiers in endocrinology 2023; (14()):1155644 doi:10.3389/fendo.2023.1155644.

    PMID: 37383390
  7. 7

    Estrogen Replacement in Turner Syndrome: Literature Review and Practical Considerations.

    Klein KO, Rosenfield RL, Santen RJ, et al.

    The Journal of clinical endocrinology and metabolism 2018; (103(5)):1790-1803 doi:10.1210/jc.2017-02183.

    PMID: 29438552
  8. 8

    Primary gonadal failure.

    Ladjouze A, Donaldson M

    Best practice & research. Clinical endocrinology & metabolism 2019; (33(3)):101295 doi:10.1016/j.beem.2019.101295.

    PMID: 31327696
  9. 9

    The Prevalence of Cataract in Children.

    Katre D, Selukar K

    Cureus 2022; (14(10)):e30135 doi:10.7759/cureus.30135.

    PMID: 36381901
  10. 10

    Evaluating the evidence for and against the use of IOLs in infants and young children.

    Kumar P, Lambert SR

    Expert review of medical devices 2016; (13(4)):381-9 doi:10.1586/17434440.2016.1153967.

    PMID: 26878234
  11. 11

    Updates on managements of pediatric cataract.

    Mohammadpour M, Shaabani A, Sahraian A, et al.

    Journal of current ophthalmology 2019; (31(2)):118-126 doi:10.1016/j.joco.2018.11.005.

    PMID: 31317088
  12. 12

    Visual axis opacification after pediatric cataract surgery - An analysis of morphology and etiology.

    Khokhar S, Chandel L, Rani D, et al.

    Indian journal of ophthalmology 2024; (72(Suppl 4)):S623-S627 doi:10.4103/IJO.IJO_2339_23.

    PMID: 38454840
  13. 13

    Psychosocial impact at the time of a rare disease diagnosis.

    Benito-Lozano J, Arias-Merino G, Gómez-Martínez M, et al.

    PloS one 2023; (18(7)):e0288875 doi:10.1371/journal.pone.0288875.

    PMID: 37506095
  14. 14

    Congenital cataract: a guide to genetic and clinical management.

    Bell SJ, Oluonye N, Harding P, Moosajee M

    Therapeutic advances in rare disease 2020; (1()):2633004020938061 doi:10.1177/2633004020938061.

    PMID: 37180497
  15. 15

    Living with a rare disease - experiences and needs in pediatric patients and their parents.

    Witt S, Schuett K, Wiegand-Grefe S, et al.

    Orphanet journal of rare diseases 2023; (18(1)):242 doi:10.1186/s13023-023-02837-9.

    PMID: 37568186
  16. 16

    19q12q13.2 duplication syndrome: neuropsychiatric long-term follow-up of a new case and literature update.

    Nacinovich R, Villa N, Broggi F, et al.

    Neuropsychiatric disease and treatment 2017; (13()):2545-2550 doi:10.2147/NDT.S142356.

    PMID: 29042784

This page is for informational purposes only and does not constitute medical advice or diagnose a genetic syndrome. Your genetics, endocrinology, and ophthalmology clinicians should interpret your results and guide decisions about hormone and cataract care.

Get notified when new evidence is published on Hypergonadotropic hypogonadism-cataract syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.